IDCCHIGH SIGNALFINANCIAL10-K

IDCC reported substantially reduced revenue alongside higher net income, creating an unusual financial profile that warrants investor scrutiny.

The combination of meaningfully lower revenue with higher net income suggests significant changes in IDCC's business mix or accounting treatment that require deeper analysis. Given IDCC's patent licensing model, this could reflect timing differences in large licensing agreements or changes in revenue recognition, but the magnitude of these opposing trends creates uncertainty about the sustainability of current profitability levels.

Comparing 2026-02-05 vs 2025-02-06View on EDGAR →
FINANCIAL ANALYSIS

IDCC's financial profile shows contradictory trends with revenue declining substantially while net income grew 13.4%, indicating either improved operational efficiency or timing-related factors in their licensing business. The balance sheet strengthened notably with cash increasing 40.1% to $739M and stockholders' equity growing 28.5% to $1.1B, while accounts receivable dropped significantly to $69.8M. The company returned more capital to shareholders through increased buybacks and dividends, suggesting management confidence despite the revenue decline.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
-62.9%
$188.3M$69.8M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Share Buybacks
Cash Flow
+53.3%
$66.7M$102.3M

Share repurchases increased 53.3% — management returning capital, signals confidence in intrinsic value.

Interest Expense
P&L
+51.9%
$29.5M$44.8M

Interest expense surged 51.9% — significant debt increase or rising rates materially impacting earnings.

Dividends Paid
Cash Flow
+45.2%
$41.8M$60.7M

Dividend payments increased 45.2% — management confidence in sustained cash generation.

Revenue
P&L
-42.3%
$532.9M$307.4M

Revenue declined 42.3% — significant demand weakness or market share loss warrants investigation.

Cash & Equivalents
Balance Sheet
+40.1%
$527.4M$739.0M

Cash position surged 40.1% — strong cash generation or capital raise providing significant financial cushion.

Stockholders Equity
Balance Sheet
+28.5%
$857.2M$1.1B

Equity base grew 28.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.

SG&A Expense
P&L
+24.9%
$49.0M$61.2M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Net Income
P&L
+13.4%
$358.6M$406.6M

Net income grew 13.4% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
+12.8%
$1.2B$1.4B

Current assets grew 12.8% — improving short-term liquidity or inventory/receivables build.

LANGUAGE CHANGES
NEW — 2026-02-05
PRIOR — 2025-02-06
ADDED
Management's Discussion and Analysis of Financial Condition and Results of Operations 28 Item 7A.
We have contributed technology to wireless standards including the 3G, 4G, 5G, and the development of 6G cellular standards and the IEEE 802.11 suite of standards.
We also develop technologies and associated patents enabling high dynamic range (HDR) production, distribution and display solutions.
We believe our patented innovations are also used in the training of video based generative AI models as well as in the distribution and storage of the content generated by such models.
InterDigital derives revenue primarily from licensing our patented innovations.
+7 more — sign up free →
REMOVED
Management's Discussion and Analysis of Financial Condition and Results of Operations 29 Item 7A.
We have contributed technology to wireless standards including the 3G, 4G, and 5G cellular standards and the IEEE 802 suite of standards.
InterDigital derives revenues primarily from licensing our patented innovations.
In 2024 and 2023, our total revenues were $868.5 million and $549.6 million, respectively.
Maintain a collaborative relationship with key industry players and worldwide standards bodies.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →